miltefosine has been researched along with Giardia duodenalis Infection in 2 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colín-Lozano, B | 1 |
| León-Rivera, I | 1 |
| Chan-Bacab, MJ | 1 |
| Ortega-Morales, BO | 1 |
| Moo-Puc, R | 1 |
| López-Guerrero, V | 1 |
| Hernández-Núñez, E | 1 |
| Argüello-Garcia, R | 1 |
| Scior, T | 1 |
| Barbosa-Cabrera, E | 1 |
| Navarrete-Vázquez, G | 1 |
| Eissa, MM | 1 |
| Amer, EI | 1 |
2 other studies available for miltefosine and Giardia duodenalis Infection
| Article | Year |
|---|---|
Synthesis, in vitro and in vivo giardicidal activity of nitrothiazole-NSAID chimeras displaying broad antiprotozoal spectrum.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antiprotozoal Agents; Drug Design; Female; Giardia | 2017 |
Giardia lamblia: a new target for miltefosine.
Topics: Administration, Oral; Animals; Antiprotozoal Agents; Female; Giardia lamblia; Giardiasis; Intestines | 2012 |